Consistent with ADAM10 mRNA findings, CD58 expression in untreated Chronic Lymphocytic Leukemia (CLL) cases remained statistically non-significant, and no significant differences were observed between treated ALL groups and controls, or between ALL and CLL groups. The gene discussed is ADAM10; the disease is B-cell chronic lymphocytic leukemia.